|
Please click below on a topic to read the instructions.
TERMS OF SUBMISSION
- Authors are strongly encouraged to review the entire 'Instructions for Authors' before submitting a manuscript to International Journal of Blood Transfusion and Immunohematology (IJBTI), to ensure that the manuscript is properly prepared and formatted. If the manuscript is not prepared according to the Instructions for Authors, it will be returned to the authors for revision before being sent for editorial review.
- All manuscripts submitted for publication in IJBTI must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med 1997;126:36-47).
- Manuscripts are considered for publication with the understanding that they have not been published previously, they have not been accepted for publication and are not currently under consideration for publication by another publisher in print or electronic medium (except in the form of an abstract or as part of a published lecture, review or thesis).
- All submissions must be made by the corresponding author only.
- The submitting/corresponding author must ensure that all co-authors have given approval for publication of the manuscript.
- It is the corresponding author's responsibility to keep all co-authors informed of the manuscript status during review and publication process.
- The manuscripts are considered as officially submitted to the Editorial Office, only after a manuscript ID has been assigned. The manuscript ID will be emailed to the corresponding author within 24-48 hours of manuscript submission.
- By submitting the manuscript to IJBTI, authors agree that, if necessary, IJBTI can edit the manuscript to improve the flow and language without altering the facts of the study.
Go to top
HOW TO SUBMIT MANUSCRIPTS
Manuscripts can be submitted to IJBTI in two ways:
- Online submission using the 'Online Submission' page of the IJBTI website.
- As an email with attached files. If the manuscript is sent by email please attach the following files: cover letter, manuscript text file and figures/images. For further instructions see 'Email Submission' page in the right column of the website.
For manuscript text files Microsoft Word document (.doc or .docx) or Rich Text Format (.rtf) are accepted formats.
Inquiries about status of submitted manuscripts or queries about the accepted manuscripts may be sent to the IJBTI Editorial Office using the "Contact Us" page. All queries will get a response at the earliest.
Go to top
IJBTI MANUSCRIPT TEMPLATES
We have prepared Microsoft Word templates for Cover Letter, Review Article, Original Article, Short Report, Case Series, Case Report and Letter to Editors.
We strongly encourage you to download the templates and use them to prepare your manuscript.
Click to download the templates and save it to your hard drive. Double click the template to open it.
Go to top
STYLE AND LANGUAGE
IJBTI accept manuscripts written in English language. Manuscripts with errors in language will be returned to the authors for corrections before sending them for editorial review.
Go to top
TYPE OF MANUSCRIPTS
The following types of manuscripts are published in IJBTI:
- Review Articles
- Original Articles
- Short Reports
- Case Series
- Case Reports
- Letter to Editors
- Announcements
Go to top
Review Articles
Scope - Review articles are welcome in International Journal of Blood Transfusion and Immunohematology (IJBTI). Review articles should have a comprehensive coverage of a topic in a clear and lucid language with representative figures and images. A structured abstract must accompany the article. Authors can submit the articles directly to IJBTI or they may discuss their proposal before writing. To discuss a proposal please contact the Editorial Office using the 'Contact Us' page or send an email to the Managing Editor.
Go to top
Original Articles
Scope - Original articles will report results of randomised controlled trials, intervention studied, case-control studies, outcome studies, studies of screening and diagnostic test and cost effectiveness analyses. A structured abstract must accompany the article.
Go to top
Short Reports
Scope - Short Reports will describe completed work on significant novel developments or important preliminary observations, therapeutic advances and any significant scientific or clinical observations into scientific or clinical aspects of transfusion medicine.
Go to top
Case Series
Scope: The Case Series section of IJBTI reports a series of 2-6 similar cases. The cases should address a challenging diagnostic and/or therapeutic problem with possible solutions to help clinician's in managing these cases. Case series must be accompanied with a comprehensive review of literature.
Go to top
Case Reports
Scope: Case Reports must provide an original description of a previously unreported entity or report new presentation of a known disease or a new perspective of case which poses a diagnostic and therapeutic challenge. Case Reports should include a comprehensive review of literature.
Go to top
Letters to the Editors
Scope: This section accepts manuscripts which report unique cases but do not qualify for other sections, results of pilot studies and comment on the articles published in IJBTI. An abstract is not required. The letter should not be divided into sections.
Go to top
Announcements
IJBTI publishes announcements of conferences, meetings, seminars, symposia, courses, and other items. The announcements should be less than 100 words. They must be accompanied by name, address and email of a contact person.
Go to top
MANUSCRIPT PREPARATION
Every submission must be accompanied by two essential files - COVER LETTER and MANUSCRIPT TEXT FILE.
COVER LETTER
A cover letter is essential and must be submitted with the manuscript.
Include the following in the Cover Letter:
- Section to which the manuscript is being submitted e.g. Review Article, Original Article, Case Report etc.
- State in the letter that:
- you wish to submit the manuscript for consideration for publication in IJBTI;
- the manuscript is being submitted by the corresponding author on behalf of all authors;
- it presents the original work of the authors;
- identical or similar work has not been published or submitted for publication elsewhere;
- all the authors made significant contribution to the study; and
- all the authors have read and approved the final version of the manuscript.
- Include in the cover letter - the full name, affiliation, academic degree(s) and email addresses of all authors.
- The covering letter should be signed by the corresponding author on behalf of all authors.
- The name of the corresponding author with contact address, contact phone number, email and fax number (if available) must be clearly listed.
We encourage you to use the Cover Letter Template for drafting your cover letter. You can replace the dummy text in red font with your manuscript details.
Click here to download the Cover Letter Template.
Go to top
GENERAL INSTRUCTIONS FOR MANUSCRIPT PREPARATION
Provide single document which includes the Title Page and manuscript text
Use Microsoft Word document (.doc or .docx) or Rich Text Format (.rtf) to prepare the document.
Use the following points to prepare and format the manuscript.
Go to top
Review Articles
- Authors: Six authors maximum
- Abstract: Structured abstract less than 250 words (Introduction, Objective, Discussion, Conclusion), followed by 3-5 keywords
- Word limit: Less than 4000 words
- Structure of manuscript: Introduction, Objective, Discussion, Conclusion
- Tables: 5 or less
- Figures: 15 or less
- References: 40 or less
Go to top
Original Articles
- Authors: Any number of authors
- Abstract: Structured abstract less than 250 words (Introduction, Aims, Methods, Results, Conclusion), followed by 3-5 keywords
- Word limit: Less than 4000 words
- Structure of manuscript: Introduction, Aims, Materials and Methods, Results, Discussion, Conclusion
- Tables: Any number
- Figures: Any number
- References: 40 or less
Go to top
Short Reports
- Authors: Six authors maximum
- Abstract: Structured abstract less than 250 words (Introduction, Aims, Methods, Results, Conclusion), followed by 3-5 keywords
- Word limit: Less than 2500 words
- Structure of manuscript: Introduction, Aims, Materials and Methods, Results, Discussion, Conclusion
- Tables: 2 or less
- Figures: 10 or less
- References: 20 or less
Go to top
Case Series
- Authors: Six authors maximum
- Abstract: Structured abstract less than 250 words (Introduction, Case Report, Discussion, Conclusion), followed by 3-5 keywords
- Word limit: Less than 2500 words
- Structure of manuscript: Introduction, Case Report, Discussion, Conclusion
- Tables: 2 or less
- Figures: 10 or less
- References: 20 or less
Go to top
Case Reports
- Authors: Four authors maximum
- Abstract: Structured abstract less than 250 words (Introduction, Case Report, Discussion, Conclusion), followed by 3-5 keywords
- Word limit: 1500 words maximum
- Structure of manuscript: Introduction, Case Report, Discussion, Conclusion
- Tables: 2 or less
- Figures: 5 or less
- References: 10 or less
Go to top
Letters to the Editors
- Authors: 4 authors maximum
- Abstract: Not required
- Word limit: 800 words maximum
- Structure of manuscript: Start the manuscript as 'To the Editors,'. Do not divide the manuscript into sections.
- Tables/Figures: 2 (1 table and 1 figure or 2 tables or 2 figures)
- References: 5 or less
Go to top
MANUSCRIPT ORGANIZATION
- Organize the manuscript as given below, in order:
- Title page
- Structured abstract
- 3-5 keywords
- Manuscript text
- Conflict of Interest
- Author's Contribution
- Acknowledgements
- References
- Illustrations
- Tables
- Figure legends
- Start main text of the manuscript on a page seperate from the abstract page.
- Use a normal, plain font for text (e.g. 12-14 point Times New Roman).
- Manuscripts should be double-spaced.
- There should be at least one inch margin all around the text.
- Number the pages consecutively, starting from the title page.
- Use hard returns at the end of paragraphs, do not use an extra hard return after each line.
- Do not use abbreviations in the title or abstract.
Incomplete or improperly prepared manuscripts will be returned to the authors for revision before being sent for editorial review.
Go to top
SPECIFIC INSTRUCTIONS FOR MANUSCRIPT PREPARATION
Title page
The first page of the manuscript the 'Title Page' should include the following:
- Type of manuscript (Review Article, Original Article, Short Report, Case Series, Case Report, Letter to Editors)
- Title of manuscript (No abbreviations in the title)
- First Name and Surname of all authors
- Highest academic qualification (e.g. M.D.)
- Academic position in the department
- Author affiliations (department, institution, city, state, country). Link author names to respective institutions by using upper case Arabic numerals.
- Name of corresponding author with contact address, contact phone number, email and fax number
- Include the statement - "Guarantor of Submission - The corresponding author is the Guarantor of Submission"
The corresponding author is considered the guarantor for the integrity of the manuscript as a whole. If authors want to designate anyone other than the corresponding author as the guarantor of submission, mention his/her name on the title page with contact address, contact phone number, email and fax number. - Short running title of the manuscript (less than 40 characters).
Go to top
Abstract
Abstract should start on a new page after the Title Page. The abstract must not exceed 250 words for any type of article.
Structure the abstract as given below:
- Review Article - Introduction, Objective, Discussion, Conclusion (less than 250 words)
- Original Articles - Introduction, Aims, Methods, Results, Conclusion (less than 250 words)
- Short Reports - Introduction, Aims, Methods, Results, Conclusion (less than 250 words)
- Case Series - Introduction, Case Report, Discussion, Conclusion (less than 250 words)
- Case Reports - Introduction, Case Report, Discussion, Conclusion (less than 250 words)
- Letters to Editors - Abstract not required
The sections in the abstract should briefly describe objectives of the study, the procedures followed, the main findings with statistical significance and the main conclusions.
Provide 3 to 5 keywords below the abstract, which will be used for indexing purposes.
Do not list anything in the abstract that is not in the manuscript.
Do not include references in abstract.
Go to top
Introduction
- In this section clearly state the purpose of the study or experiment and summarise the rationale for the study or observation.
- Give here only pertinent references.
- Do not review the subject extensively.
- Do not include data or conclusions from the work being reported in the paper.
Go to top
Materials and Methods
- Give here only the information included in the plan or protocol of the study, before the data collection or patient recruitment was started. Any information or data collected during the study period should be presented in the Results section.
- Describe the criteria used for selecting observational or experimental subjects. Give the number of subjects in each study group with details about randomization. Describe the methods used for blinding of observations.
- Identify the methods, apparatus, equipment, reagents, and procedures used in sufficient detail to allow other colleagues to reproduce the results. When a reagent, an apparatus or any equipment is mentioned for the first time in the text, provide in parenthesis the model name or number, manufacturer's name and location. Identify precisely all drugs and chemicals used, including generic name(s), dose(s) and route(s) of administration.
- Avoid any details which might identify the patient(s) unless absolutely necessary. If identification of patient(s) is unavoidable, informed consent must be obtained from the patient and submitted to the Editorial Office.
- All manuscripts dealing with recombinant DNA research must indicate the physical and biologic containment procedures practiced, in accordance with the Health Guidelines for Research Involving Recombinant DNA Molecules established by the National Institutes of Health.
- All randomised controlled trials submitted for publication in IJBTI should present information on the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups) and the method of masking (blinding). Include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart with all manuscripts. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information.
Reporting Guidelines for Specific Study Designs
Go to top
Statistical Anlysis
- Put in a separate paragraph, in the Materials and Methods section, a general description of the statistical methods used.
- Specify the statistical methods used to analyse diferent variables. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals).
- For all P values include the exact value and not less than 0.05 or 0.001.
- References for study design and statistical methods should be to standard works when possible.
- Specify any software/computer programe used for analysing data.
Go to top
Results
- Present the results in logical sequence using text, tables, illustrations and graphs.
- Report losses to observation (such as dropouts from a clinical trial).
- Report treatment complications.
- Specify the numbers of observations.
- Do not repeat in the text any data presented in tables and/or illustrations.
- Present the numeric data both as the absolute numbers and as derivatives (e.g. percentages) and specify the statistical methods used to analyze them.
- Use graphs as an alternative to tables with many entries.
Go to top
Discussion
- Include a summary of key findings in the first paragraph of 'Discussion' section.
- Give a comprehensive review of literature.
- Emphasize the new and important aspects of the study and the conclusions that follow from them.
- Include in the 'Discussion' the interpretation and implications of the findings and future research directions. Recommendations, when appropriate, may be included.
- Give the strengths and limitations of the study (study question, study design, data collection, analysis and interpretation).
- Do not repeat in detail, data or other material given in the 'Introduction' or 'Results' section or tables and illustrations.
- Avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses.
- State new hypotheses when warranted, but clearly label them as such.
Go to top
Conclusions
Conclusion should highlight the main points learnt from the case in a short paragraph of 3-4 sentences.
Go to top
For Case Series and Case Reports only
- In the 'Case Report' section in both type of manuscripts, give all the relevant details about the case(s).
- Describe the patient's present and past medical history; presenting symptoms and signs; results of laboratory tests, description of any treatment or intervention.
- Illustrate the case with figures and tables.
Go to top
List of abbreviations
If abbreviations are used in the text, either they should be defined in the text when first used or a list of abbreviations can be provided before the references.
Go to top
Conflict of Interest
- All authors must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript or a competing product to the one mentioned in the manuscript and/or is important to the outcome of the study presented.
- All funding sources supporting the work, and institutional or corporate affiliations of the author(s), should be acknowledged here.
- All conflict of interests will be listed at the end of the published article. If the author(s) gives no conflict of interests, the following sentence will be used - 'The author(s) declare no conflict of interests'.
Go to top
Author's Contribution
- The individual contribution of all the authors to the work described in the manuscript will be published with the article.
- Once the manuscript is submitted, the order of authors cannot be changed without written consent from all the authors.
To be eligible for authorship, an individual must complete at least one task from each group listed below.
- Group1 - Conception and design, Acquisition of data, Analysis and interpretation of data
- Group 2 - Drafting the article, Critical revision of the article
- Group 3 - Final approval of the version to be published
All contributors who do not meet the criteria for authorship should be listed in the acknowledgements section.
Go to top
Acknowledgements
In this section acknowledge anyone who contributed towards the study by making contributions like arranging for funds, general supervision, contribution of materials essential for the study or technical assistance. Authors must obtain permission from all persons mentioned in this section to acknowledge them.
If text and/or figures are being reprinted with the permission of an author or publisher, acknowledge them in this section.
Go to top
References
The maximum number of references for the articles published in IJBTI are given below.
- Review articles - 40 or less
- Original articles - 40 or less
- Short Report - 20 or less
- Case series - 20 or less
- Case reports - 10 or less
- Letters to Editors - 5 or less
Authors of the manuscript are responsible for the accuracy of references.
- All references in text, tables, and legends must be identified by consecutive Arabic numerals in parenthesis, listed before the closing punctuation mark. There should not be any space between the reference numbers in parenthesis. E.g. (1) or (1,2) or (1-4) or (1-4,6) or (1,2,5-7) or (1,4-5,8,11-16)
- References cited only in tables or figure legends should be numbered in continuation with references in the text. (e.g. If the last reference cited in the text is 11, number the next reference cited only in table as 12.)
- Place the references immediately after the author name or if author name is not included in the sentence, at the end of the sentence after the punctuation mark.
- In the 'Reference' section, number each reference consecutively in the order in which they are first mentioned in the text (not in alphabetic order).
- Each reference must have a reference number.
- References should not be used in titles or headings.
- List all authors up to 6; if more than 6, list the first 6 followed by 'et al.'
- Abbreviate the journal titles according to the style used in Index Medicus/PubMed.
- Use complete journal names for non-indexed journals.
- Avoid using abstracts as references.
- Avoid citing unpublished data or manuscripts, personal communications, web sites, conference papers and non-peer reviewed publications.
- Avoid citing text books as references and very old references.
- If personal communication is cited, it should be listed at the appropriate location in the text, in parenthesis, after punctuation. Do not include it as a reference. For personal communications include the following in parenthesis - name of individual, highest academic qualification, institute, country, year the information was obtained and whether it was oral or written communication. Authors who cite personal communications must obtain written permission from all cited individuals.
- Please take extreme care in following the reference style given below. Manuscripts with references not formatted in the correct style will be returned to the authors for revision before being sent for Edtorial Review.
- References must follow the general arrangement and punctuation outlined in International Committee of Medical Journal Editors Uniform requirements for manuscripts submitted to biomedical journals. Ann Intern Med, 1988;108:258-265 or Br Med J. 1988;296:401-405.
- References should be typed, double-spaced, after the acknowledgements. Provide inclusive page numbers for all references.
The general format of the references is:
Author Surname followed by Initials. Article title. Abbreviated journal name year;volume(number):inclusive page numbers.
No space between - year;volume(number):inclusive page numbers.
Example of IJBTI reference style are shown below.
Article within a journal
Koonin EV, Altschul SF, Bork P. BRCA1 protein products: functional motifs. Nat Genet 1996;13(4):266-267.
Web Links
Include the website name followed by the full URL:
Online-only Articles
Gossner J. Lissencephaly Type 1. PedRad [serial online] 2008;8(5). Available at: www.PedRad.info/?search=20080522125523. Accessed June 10, 2008.
Volume with supplement
Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102Suppl 1:275-282.
Issue with supplement
Payne DK, Sullivan MD, Massie MJ. Women's psychological reactions to breast cancer. Semin Oncol 1996;23(1,Suppl 2):89-97.
Organization as author:
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40(5):679-686.
Both personal authors and an organization as author:
Munakata M, Honma H, Akasi M; for J-STOPMetS Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. Vasc Health Risk Manag 2007;4(2):415-420.
Issue with no volume:
Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop 2002;(401):230-238.
No volume or issue:
Outreach: bringing HIV-positive individuals into care. HRSA Careaction 2002 Jun:1-6.
Article published electronically ahead of the print:
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood 2002 Epub Jul 5.
Article in other language
Nakajima T. Tabular analysis of 10 000 cases of gastric cancer in the Cancer Institute Hospital (in Japanese). Gan to Kagakuryoho. Jpn J Cancer Chemother 1994;21:1813-1897.
Article in other language with English abstract
Imada T, Takehana T, Rino Y, Suzuki M, Takahashi M, Chin C, et al. Indications for pylorus-preserving gastrectomy for early gastric cancer (in Japanese with English abstract). Nihon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 1995;28:2248-2255.
In press article
Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press.
Published abstract
Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999;42:s250.
Article within conference proceedings
Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann;1996:16-27.
Conference proceedings:
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
Book
Watanabe H, Jass JR, Sobin LH. Histopathological typing of oesophageal and gastric tumours, 2nd ed. Berlin Heidelberg New York: Springer; 1990. p. 23.
Book chapter
Wyatt JI. Helicobacter pylori, duodenitis and duodenal ulceration. In: Rathbone BJ, Heatley RV, editors. Helicobacter pylori and gastroduodenal disease. 2nd ed. Oxford: Blackwell; 1992. p. 140-9.
Go to top
Tables
- Tables should be provided before figure legends.
- The table numbers should be cited at the relevant places in the text in parenthesis after the punctuation mark. E.g. (Table 1) or (Tables 1-4) or (Tables 1, 4, 6-8).
- Each table should be numbered in the order of first citation in the text, using Arabic numerals (e. g. Table 1).
- Each table should appear on a separate page.
- A title for every table which summarizes the whole table must be given above the table.
- Tables should be self-explanatory and not duplicate the data presented in figures.
- Kindly prepare tables using the table function of word processing program like Microsoft Word. Do not use spaces or tabs for making tables.
- Charts should be sent as Excel or PowerPoint files.
- Place explanations, comments and full form of non-standard abbreviations in footnotes below each table.
- If some material has been taken from previously published literature, give the reference at the end of the table caption, and include the citation in the list of references at appropriate places.
- For footnotes use superscript lower case letters.
Go to top
Illustration
- Illustrations include figures, photomicrographs and photographs.
- The following file formats are accepted for illustrations: JPG, JPEG, PNG, TIFF, BMP, GIF, PowerPoint
- Figure files should have a minimum resolution of 300 pixels per inch (ppi) if in color or halftone, or 1200 ppi if as line art. Digital scanned line drawings should have a minimum resolution of 800 dpi. Digital color files must be saved using CMYK or RGB mode.
- Figures should be numbered consecutively according to the order in which they have been first cited in the text.
- Make all efforts to preserve the anonymity of the patients. If photographs of an individual is used in which a person can be identified, written informed consent must be obtained and submitted to the Editorial Office.
- Mention the figure numbers in the text at the appropriate places in parenthesis after punctuation marks. E.g. (Figure 1) or (Figures 1A, 2) or (Figures 1A, 1C, 3-4) or (Figures 1-3) or (Figures 1, 4-6)
- Do not include images in the main manuscript text file. All figures should be provided as separate files.
- Include colored figures wherever possible.
- The file name should include the figure number. Label file names as: Figure 1, Figure 2 etc.
- Try to keep all images separate. You do not need to combine multiple images into a single image.
- If it is necessary to combine multiple figures into one composite figure, figure parts should be denoted on the figure by uppercase letters (A, B, C, etc.). Label each figure in the lower left-hand corner (for Figure 1 (A), label figure as 'A', for Figure 1 (B), label figure as 'B', without quotes). Labels should not include the word 'Figure.' The size of the letters should be large enough to be easily visible in case the figure is reduced in size. Use Arial (sans serif) font to add labels. Keep letters of a consistent size in all the figures. Use font color so that the letters contrast with the background. You can use symbols, arrows or letters in the figures to indicate important areas or parts. Do not put the title of figures or explanations on the figure. Mention them in the figure legends.
- Please provide legends for illustrations, double-spaced, on a separate page in the manuscript, with Arabic numerals corresponding to the figures.
- The legends should be included in the manuscript text file immediately following the tables.
- Figure legend should begin with the term 'Figure' followed by figure number (e.g. 'Figure 1'). Do not include any punctuation after the figure number or at the end of the figure legend.
- Give a good description of the figures. When arrows, symbols or letters are used to identify parts of a figure, identify and explain each one in the legend. Give the magnification and identify the method of staining in photomicrographs.
- Do not use any abbreviations unless their full forms are given (excluding common abbreviations such as names of antibodies).
- If any person is identifiable in a photograph, written permission must be taken form the subjects(s). Please submit a copy of the permission letter at the time of submittting the Copyright Assignment Form.
- The Journal reserves the right to modify, crop, rotate, reduce, or enlarge the photographs to an acceptable size.
- If a figure has been published elsewhere, you will have to submit written permission from the copyright holder to reproduce the material at the time of submitting the Copyright Assignment Form.
- If you include text or figures that have been published elsewhere, you must obtain permission from the copyright owner(s). All expenses for obtaining such permission will have to be paid by the author(s). If you are unable to pay for obtaining permission to use previously published work, we suggest that you use other work available free to refer and cite in your manuscript.
Go to top
ETHICS
- When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards given in the Declaration of Helsinki of 1975, as revised in 2000 (available at: http://www.wma.net/en/30publications/10policies/b3/index.html).
- The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that subjects gave informed consent to the work.
- Studies involving experiments with animals must state that their care was in accordance with institution's or national research council's guidelines for, or any national law on the care and use of laboratory animals. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated.
- Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand.
Go to top
REGISTRATION OF CLINICAL TRIALS
- International Journal of Blood Transfusion and Immunohematology (IJBTI) has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which requires, registration of clinical trials in a public trials registry, as a condition of consideration for publication of an article in IJBTI.
- Trials must register at or before the onset of patient enrollment. The clinical trial registration number should be included at the end of the abstract of the article.
- For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes.
- Health-related interventions include any intervention used to modify a biomedical or health-related outcome.
- Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.
- Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at www.icmje.org.
Go to top
FORMS TO BE SUBMITTED
- Copyright Assignment Form (Required)
- Patient's Consent to Publish Identifying Information (Required if any identifying information is included in text or figures)
- Permission to Reproduce Published Material (Required if any previously published material is used in the manuscript)
All the forms can be submitted to the Editorial Office either as scanned images (e.g. JPG or JPEG format) or as PDF files.
You are welcome to upload all forms through our website or send them as email attachments.
- Upload on website - Use the 'Submit All Forms' page accessible from the right navigation menu.
- Submit by email - Submit the forms as email attachments to:
- Fax to: +1-773-409-5040. If the Copyright Assignment Form is sent by fax, the faxed forms must have legible names and signatures.
Note: If submitting through the website please note that there are five upload boxes for five pages of the Copyright Assignment Form and other upload boxes for other type of forms. You can upload each page of any form separately if uploading it as an image or submit all pages together as one if uploading it as PDF file. You can submit multiple forms at the same time if required.
Go to top
COPYRIGHT ASSIGNMENT FORM
Authors retain the copyright of their work for all articles published in International Journal of Blood Transfusion and Immunohematology (IJBTI).
After acceptance of the manuscript, it is necessary that the corresponding author, on behalf of all authors, signs and submits a Copyright Assignment Form. The manuscript cannot be published until a completed form is received by the Editorial Office.
The Copyright Assignment Form includes the following sections, all of which have to be signed separately.
- Section - I: Integrity and originality of manuscript
- Section - II: Open access agreement
- Section - III: Rights of authors and publishers
- Section - IV: Permission to reproduce published material
- Section - V: Patient's consent to publish
- Section - VI: Conflict of interest
Please ensure you include the Manuscript ID number, title of the manuscript and names of all authors in the form. (The manuscript number will be emailed to you immediately after manuscript submission).
All author names must be typed or printed clearly and legibly on the form.
Go to top
CONSENT FOR IDENTIFYING INFORMATION
Any information which can identify the patient should not be published in text, photographs, ultrasonograms, CT scans, etc. unless the information is essential for scientific purposes.
If you want to include any information like photograph, name, address, etc, in any part of the manuscript by which the identity of patient can be revealed; you must obtain written, informed consent from the patient and submit a copy of the document to the Editorial Office.
Corresponding author will have to sign a statement to this effect in the Copyright Assignment Form.
Go to top
REPRODUCTION OF PUBLISHED MATERIAL
If you wish to reproduce text, figures or tables that have already been published elsewhere, you must obtain permission from the copyright owner(s).
A statement stating that such permission was obtained will need to be signed by the corresponding author in the Copyright Assignment Form. Please submit a copy of the permission letter or other evidence that such permission has been granted along with the Copyright Assignment Form after the manuscript has been accepted for publication in IJBTI.
It is the author's responsibility to pay any fees associated with publishing data from another source.
Go to top
CORRECTIONS AND RETRACTIONS
If any errors occur during the publication process, the Editor will discuss these errors with the corresponding author. If agreed upon, a correction will be published. If an error is discovered by the author in their work after publication, this should be discussed with the Editor, who will make a decision regarding publication of a correction.
If a paper containing fraudulent data has been published, the journal will print a retraction. The retraction will be listed in the contents page. Retraction will include the title of the original article, and will explain why the article is being retracted.
Go to top
ARTICLE PUBLICATION CHARGES
All work published in International Journal of Blood Transfusion and Immunohematology (IJBTI) is open access and freely available, published and distributed under Creative Commons Attribution 3.0 License.
Open access publishing allows unrestricted use, distribution and reproduction of an article in any medium, provided that the original work is properly cited and due credit is given to authors and original publisher.
Full-text of all articles published in IJBTI is available online, worldwide, free of charge, immediately on publication. Readers can view, download, print, and redistribute any article without a subscription, enabling a much greater distribution of an author's work. This translates into increasing the impact of the authors published work.
In an open access model, authors contribute towards the publication costs of an article. Publication charges can be paid from an author's research budget or by their supporting institution.
The Article Publishing Charges for IJBTI will be billed to the corresponding author upon acceptance of the article. There is no fee for submission of the article.
The current Article Publication Charges for IJBTI is $490 per article. Our fees are on an average 3 to 5 times lower than those charged by other journals ($490 for IJBTI versus $1500-2500 charged by other journals). We have kept the rates low to help everyone publish their work in IJBTI, without worrying for funds to pay for the fees.
The payment can be made by Credit Card, PayPal or by Western Union money transfer. The details about how to make the payment will be sent to you after the manuscript has been peer reviewed and accepted for publication.
Discounts or full waiver of Article Publishing Charges may be granted. The amount of discount will depend on factors such as country of origin, position of the author in the institute and quality and originality of the work.
To apply for a waiver, contact the Editorial Office using the 'Contact Us' page giving your name, address, institution, title of the paper, a short summary of the work and reason for requesting a waiver.
Please DO NOT submit your manuscript before you have received the decision from the Editorial Office. You will be informed of the decision on the waiver application within three working days. Please understand that waivers are granted on a case by case basis and there is no guarantee that a discount or waiver will be granted.
Go to top
SUBMISSION OF REVISED MANUSCRIPTS
While submitting a revised manuscript, contributors are requested to include a point by point response to reviewer's comments at the beginning of the revised manuscript text file itself. In addition, if any changes are made to the manuscript, please mark the changes as underlined or differently colored text in the article.
Go to top
PAGE PROOFS
Page proofs of the manuscript, a form for marking corrections of the proofs and instructions for filling the form will be sent to the corresponding author by e-mail, before publication of the manuscript. Authors should type the proof corrections in the form and send it to the Editorial Office.
While checking the proofs, take note that the text is complete and all figures and tables are included in the proofs. Respond to all queries from the Editorial Office, check the proofs for changes like spellings, punctuation and setting of text, tables, figures and figure legends. Do not make any substantial changes to the text or change figures or tables or their legends. If substantial changes need to be made please contact the Editorial Office.
IJBTI reserves the right to contact another author if the corresponding author is not available to check proofs. Authors must adhere to acceptable use of American English and syntax. The Editor reserves the right to make corrections, both literary and technical, to the papers. Authors should keep a complete copy; rejected manuscripts will not be returned.
Corrected proofs must be returned to the Editorial office within 72 hrs (3 days) of receipt.
The page proofs can be sent to the Editorial Office by uploading through our website or as email attachments or fax.
- Upload on website - Upload using the 'Submit Page Proofs' in the right navigation menu.
- Submit by email -
- Submit by Fax - Send the corrected proofs to: +1-773-409-5040
Go to top
|
